Skip to main navigation
Skip to main content
  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs
  • Careers
  • Partnerships & Business Development
  • esperionscience.com
  • Contact Us
  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs
  • Our Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Ethics and Compliance
    • Corporate Governance & Committee Composition
  • Patients
    • Cholesterol Education
    • Unmet Need
    • Patient Advocacy and Resources
  • Products
  • Science
    • Scientific Advisory Board
    • Pipeline
    • Clinical Trials
    • Expanded Access
    • Grants
  • Partnerships & Business Development
/investors-media

Investors and Media

Latest News

Jun 08, 2023
Esperion to Present New Key Science at the American Diabetes Association’s 83rd Scientific Sessions 2023
Jun 05, 2023
Esperion to Present Additional Analyses from the Landmark CLEAR Outcomes Study at ENDO 2023

View All News Dark Blue

  • View All News
Show all

Latest Quarterly Results

  • Esperion Reports First Quarter 2023 Financial Results
  • Esperion Q1 Earnings Presentation 2.5 MB
  • Form 10-Q

View All Earnings

  • View All Earnings

Corporate Presentation

Download PDF

Events

Upcoming Events

Jun 15, 2023 at 8:00 AM EDT
Esperion Therapeutics, Inc. 2023 Annual Meeting of Stockholders

Past Events

Jun 7, 2023 at 11:30 AM EDT
Jefferies Healthcare Conference
May 15, 2023 at 2:00 PM EDT
JMP Securities Life Sciences Conference

View All Events

  • View All Events

Investors:
Alexis Callahan
investorrelations@esperion.com
(406) 539-1762

Corporate Inquiries & Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438

Page Tools

Our Company

  • Our Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Ethics and Compliance
    • Corporate Governance & Committee Composition

Patients

  • Patients
    • Cholesterol Education
    • Unmet Need
    • Patient Advocacy and Resources

Products

  • Products

Science

  • Science
    • Scientific Advisory Board
    • Pipeline
    • Clinical Trials
    • Expanded Access
    • Grants

Careers

  • Careers

Partnerships & Business Development

  • Partnerships & Business Development

Investors & Media

  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs

esperionscience footer

  • esperionscience.com

Contact Us

  • Contact Us

All trademarks and trade names are the property of their respective owners.

© 2023 Esperion Therapeutics, Inc. All rights reserved. 05/20 US-CRP-2000082

Utility

  • Privacy Policy
  • Terms of Use
  • Accessibility Statement
  • Social Media Community Guidelines

Search

Share this page